🟢 Breaking 🚨: Samraat S. Raha, President and CEO, just made an open-market purchase in Myriad Genetics Inc. ($MYGN), buying 40,000 shares at $5.00 per share — a total investment of $199,844, increasing his stake by +8.83%.